Pharmacokinetic analysis of piperacillin administered with tazobactam in critically Ill, morbidly obese surgical patients.

被引：0
|
作者：
Sturm, Ashley W. [1 ]
Allen, Nichole [1 ]
Rafferty, Kelly D. [1 ]
Fish, Douglas N. [2 ]
Toschlog, Eric [1 ]
Newell, Mark [1 ]
Waibel, Brett [1 ]
机构：
[1] Vidant Med Ctr, Greenville, NC USA
[2] Univ Colorado, Aurora, CO USA
来源：
PHARMACOTHERAPY | 2013年 / 33卷 / 10期
关键词：
D O I：
暂无
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
167E
引用
收藏
页码：E232 / E233
页数：2
相关论文
共 50 条
  • [41] Timing of Tracheotomy in Mechanically Ventilated Critically Ill Morbidly Obese Patients
    Alhajhusain, Ahmad
    Ali, Ailia W.
    Najmuddin, Asif
    Hussain, Kashif
    Aqeel, Masooma
    El-Solh, Ali A.
    CRITICAL CARE RESEARCH AND PRACTICE, 2014, 2014
  • [42] Timing Of Tracheotomy In Mechanically Ventilated Critically Ill Morbidly Obese Patients
    Ali, A. W.
    Alhajhusain, A.
    Aqeel, M.
    Najmuddin, A.
    Hussain, K.
    El Solh, A.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2014, 189
  • [43] Third generation cephalosporins and piperacillin/tazobactam have distinct impacts on the microbiota of critically ill patients
    Gamage, Hasinika K. A. H.
    Venturini, Carola
    Tetu, Sasha G.
    Kabir, Masrura
    Nayyar, Vineet
    Ginn, Andrew N.
    Roychoudhry, Belinda
    Thomas, Lee
    Brown, Mitchell
    Holmes, Andrew
    Partridge, Sally R.
    Seppelt, Ian
    Paulsen, Ian T.
    Iredell, Jonathan R.
    SCIENTIFIC REPORTS, 2021, 11 (01)
  • [44] We need to optimize piperacillin-tazobactam dosing in critically ill patients-but how?
    Cotta, Menino Osbert
    Roberts, Jason A.
    Lipman, Jeffrey
    CRITICAL CARE, 2016, 20
  • [45] Steady-state pharmacokinetics and pharmacodynamics of piperacillin and tazobactam administered by prolonged infusion in obese patients
    Cheatham, S. Christian
    Fleming, Megan R.
    Healy, Daniel P.
    Chung, Christina E. K.
    Shea, Katherine M.
    Humphrey, Melissa L.
    Kays, Michael B.
    INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS, 2013, 41 (01) : 52 - 56
  • [46] Third generation cephalosporins and piperacillin/tazobactam have distinct impacts on the microbiota of critically ill patients
    Hasinika K. A. H. Gamage
    Carola Venturini
    Sasha G. Tetu
    Masrura Kabir
    Vineet Nayyar
    Andrew N. Ginn
    Belinda Roychoudhry
    Lee Thomas
    Mitchell Brown
    Andrew Holmes
    Sally R. Partridge
    Ian Seppelt
    Ian T. Paulsen
    Jonathan R. Iredell
    Scientific Reports, 11
  • [47] Is therapeutic drug monitoring really helpful for managing piperacillin/tazobactam therapy in critically ill patients?
    Novy, Emmanuel
    Francois, Thomas
    Luc, Amandine
    Pape, Elise
    Scala-Bertola, Julien
    INTENSIVE CARE MEDICINE, 2022, 48 (11) : 1676 - 1678
  • [48] Prolonged vs intermittent infusion of piperacillin/tazobactam in critically ill patients: A narrative and systematic review
    Yusuf, Erlangga
    Spapen, Herbert
    Pierard, Denis
    JOURNAL OF CRITICAL CARE, 2014, 29 (06) : 1089 - 1095
  • [49] The effect of meropenem versus piperacillin-tazobactam in critically ill patients with sepsis and septic shock
    Sun, Yang
    Liu, Yu
    Wang, Jixia
    Cui, Can
    HELIYON, 2023, 9 (06)
  • [50] Is therapeutic drug monitoring really helpful for managing piperacillin/tazobactam therapy in critically ill patients?
    Emmanuel Novy
    Thomas François
    Amandine Luc
    Elise Pape
    Julien Scala-Bertola
    Intensive Care Medicine, 2022, 48 : 1676 - 1678
12345